Internal Medicine, Nephrology · Memphis, TN
NPI
1689603102
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6027 Walnut Grove Rd Ste 402
Memphis, TN, 38120
Phone (901) 767-0304
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
32,305 services
Medicare patients, 2024
1,438
Average age 75
Drug cost, 2024
$1.8M
10,791 prescriptions
Company payments, 2025
$1,194
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjeev K Mittal was code 99458 (e&m - miscellaneous), 9,877 times for 490 patients. In total Sanjeev K Mittal billed 32,305 services in 27 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 9,877 | 490 | $28.31 | $280K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 5,234 | 362 | $33.62 | $176K |
| 99457 E&M - Miscellaneous | Office | 4,702 | 528 | $34.24 | $161K |
| 99454 E&M - Miscellaneous | Office | 4,455 | 491 | $31.46 | $140K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,853 | 365 | $45.14 | $129K |
| 99214 Office E&M - Established | Office | 2,100 | 1,056 | $83.56 | $175K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,205 | 799 | $12.07 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 365 | 81 | $257.34 | $94K |
| 99204 Office E&M - New | Office | 277 | 277 | $107.01 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 98 | $57.44 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 233 | 93 | $85.48 | $20K |
| 93976 Duplex Scan - Extremity Arteries | Office | 160 | 160 | $66.61 | $11K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 157 | 157 | $45.98 | $7,218 |
| 90966 ESRD Related Services (not dialysis) | Office | 148 | 20 | $208.34 | $31K |
| 99453 E&M - Miscellaneous | Office | 93 | 89 | $12.77 | $1,188 |
By year: 2022 $841K for 16,040 services; 2023 $1.2M for 27,363 services; 2024 $1.3M for 32,305 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanjeev K Mittal prescribed most often to Medicare patients was Torsemide, with 994 prescriptions and refills. In total Sanjeev K Mittal wrote 10,791 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Torsemide Generic | 994 | 2,620 | 349 | $18K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 839 | 2,318 | 283 | $37K |
| Calcitriol Generic | 633 | 1,740 | 219 | $7,513 |
| Amlodipine Besylate Generic | 607 | 1,670 | 241 | $3,614 |
| Valsartan Generic | 485 | 1,303 | 176 | $17K |
| Hydralazine Hcl Generic | 462 | 1,257 | 187 | $7,547 |
| Allopurinol Generic | 448 | 1,240 | 159 | $5,325 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 348 | 961 | 130 | $12K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 342 | 901 | 126 | $3,839 |
| Farxiga Dapagliflozin Propanediol | 312 | 668 | 114 | $357K |
| Spironolactone Generic | 309 | 796 | 103 | $2,771 |
| Olmesartan Medoxomil Generic | 247 | 695 | 106 | $5,021 |
| Clonidine Hcl Generic | 233 | 609 | 86 | $1,989 |
| Carvedilol Generic | 225 | 650 | 91 | $2,071 |
| Losartan Potassium Generic | 215 | 583 | 80 | $2,180 |
Brand drugs: 1,019 claims; generic drugs: 9,772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjeev K Mittal $1,194 ($1,194 in general payments such as food, travel and fees) from 14 companies. The largest payer was Lilly USA, LLC with $216.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 7 | $216 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $213 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $122 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $98.12 |
| Travere Therapeutics, Inc. TVTX | 9 | $90.58 |
| Ardelyx, Inc. ARDX | 3 | $81.14 |
| Calliditas Therapeutics US Inc. | 2 | $56.26 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $48.11 |
| Fresenius USA Marketing, Inc. | 2 | $43.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.